Infectious Disease

TIGR and NIAID sign $65 million microbial sequencing contract

Published in Vaccine Weekly, October 22nd, 2003

The Institute for Genomic Research (TIGR) has signed a 5-year, $65 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health, to sequence and analyze the genomes of pathogenic microbes and invertebrate vectors of infectious diseases for the wider scientific community.

Under the contract, TIGR will sequence dozens of genomes per year.

"We look forward to working in partnership with NIAID to help meet the needs of the infectious disease research community for genomic data and analysis," said TIGR President Claire M. Fraser, PhD.

TIGR's affiliated...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2003-10-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry